Valley National Advisers’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Valley National Advisers’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5,065	Closed	-$36K	–	894
2020 Q1	$36K	Buy	5,065 +1,019	+25%	+$12.7K	0.01%	316
2019 Q4	$97K	Hold	4,046	–	–	0.02%	249
2019 Q3	$109K	Hold	4,046	–	–	0.03%	234
2019 Q2	$110K	Buy	4,046 +981	+32%	+$30.8K	0.03%	225
2019 Q1	$106K	Sell	3,065 -981	-24%	-$28.3K	0.03%	230
2018 Q4	$79K	Sell	4,046 -391	-9%	-$8.04K	0.03%	229
2018 Q3	$118K	Buy	4,437 +1,417	+47%	+$46.3K	0.04%	203
2018 Q2	$114K	Buy	3,020 +970	+47%	+$37.1K	0.04%	205
2018 Q1	$67K	Buy	2,050 +800	+64%	+$35.1K	0.02%	229
2017 Q4	$61K	Hold	1,250	–	–	0.02%	232
2017 Q3	$68K	Hold	1,250	–	–	0.02%	229
2017 Q2	$70K	Hold	1,250	–	–	0.03%	219
2017 Q1	$49K	Buy	1,250 +1,000	+400%	+$31.8K	0.02%	239
2016 Q4	$6K	Hold	250	–	–	﹤0.01%	475
2016 Q3	$6K	Buy	250 +100	+67%	+$2.35K	﹤0.01%	446
2016 Q2	$4K	Hold	150	–	–	﹤0.01%	481
2016 Q1	$3K	Hold	150	–	–	﹤0.01%	515
2015 Q4	$8K	Buy	+150	New	+$7.27K	﹤0.01%	411

Other funds holding PTLA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Valley National Advisers's PTLA Position: Q2 2020 in Review

Valley National Advisers sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 5,065 shares — an estimated $36K sold.

Valley National Advisers first reported a position in PTLA in Q4 2015 and held it in 18 quarters. The position peaked at $118K in Q3 2018. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

Valley National Advisers reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
Valley National Advisers sold 5,065 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $36K.
Valley National Advisers first reported a position in Portola Pharmaceuticals, Inc. in Q4 2015 and held it in 18 quarters.
Valley National Advisers's Portola Pharmaceuticals, Inc. position peaked at $118K in Q3 2018.
162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Valley National Advisers's 13F filing for Q2 2020, filed 10 Aug 2020.